Actualización de las recomendaciones sobre el uso de la monitorización ambulatoria de presión arterial. Documento de consenso de la Sociedad Chilena de Hipertensión

ISSN: 00349887
2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Before the development of purified insulin in the 1970s, lipoatrophy was a common complication of insulin therapy (1,2). With the arrival of human insulin, lipoatrophy has decreased dramatically, becoming a rare problem in clinical practice. Lipoatrophies are considered an adverse immunological side effect of insulin therapy, and in some cases they are mediated by a local high production of tumor necrosis factor-α, which leads to a dedifferentiation of adipocytes in the subcutaneous tissue. The treatment with corticosteroids is useful because of its immunomodulating properties and also because it is able to produce a differentiation of adipocytes (2–4).In most reported cases of insulin-induced lipoatrophies, there were attempts of changing the injection areas without any evidence of improvement (5–8). Kumar et al. (9) in a single-blind study used small amounts of dexamethasone, adding 4 μg/unit to insulin injections, in nine patients with marked lipoatrophy in both thighs. A mix of insulin and dexamethasone was injected into one thigh and insulin without dexamethasone was injected into the other. This way, each patient was her own control subject. Six patients showed significant improvement. None used …

Author supplied keywords

Cite

CITATION STYLE

APA

Prat M, H., Valdés S, G., Román A, Ó., & Zárate M, L. H. (2009). Actualización de las recomendaciones sobre el uso de la monitorización ambulatoria de presión arterial. Documento de consenso de la Sociedad Chilena de Hipertensión. Revista Medica de Chile, 137(9), 1235–1247.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free